Pure Global
NCT06360510

Comparison of %5 Dextrose and Betamethasone Injections in Patients With Carpal Tunnel Syndrome

Comparison of the Effectiveness of Ultrasound-guided 5% Dextrose and Betamethasone Injections in Patients With Carpal Tunnel Syndrome.
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital·ClinicalTrials.gov·procedureRecruitment Completed
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Carpal Tunnel Syndrome
Drug/Device/Intervention
%5 dextrose injection
Study type
Observational
Intervention type
procedure
Sponsor & location
Primary sponsor
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Location
Ankara, Turkey
Timeline & enrollment
Phase
N/A
Start date
May 05, 2023
End date
May 05, 2024
Enrollment
30 participants
Primary outcome

vas

Summary

The aim of the study is to compare the effectiveness of ultrasound-guided betamethasone and
 5% dextrose injection, which is routinely applied in clinical practice, in patients with mild
 and moderate carpal tunnel syndrome (CTS).

ICD-10 classifications
Carpal tunnel syndromeTarsal tunnel syndromeArthrosis of first carpometacarpal joint, unspecifiedArthrosis of first carpometacarpal jointOther specified disorders of synovium and tendon
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06360510
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06360510 through Pure Global AI's free database. This phase not specified trial is sponsored by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital and is currently Recruitment Completed. The study focuses on Carpal Tunnel Syndrome. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.